Can fenbendazole fight cancer on its own?

Recently, researchers have been experimenting with Fenbendazole for human cancer. Though the studies are limited, what researchers have found so far is promising for cancer patients, many of whom have started using the Fenbendazole for Cancer Protocol. In recent years, scientists have ramped up their efforts to study Fenbendazole, in clinical trials. The most recent studies have also shown Fenbendazole can potentially be used to treat Pancreatic, Ovarian and colorectal cancer.

Fenbendazole has been studied for its potential to interfere with the glucose intake of cancer cells. Glucose is essential for cancer growth and proliferation. This interference leads to a decrease in cancer cells both in laboratory settings and in live subjects. It starves the cancer cells of the glucose they need to grow and divide. Fenbendazole was shown to kill cancerous cells and promote regression in cancer patients with large B-cell lymphoma that had metastasized. It was also found for other metastatic malignancies such as bladder cancer, renal cell carcinoma, and more.

Fenbendazole can work alongside traditional cancer therapies to decrease cancer cells. For example, one study found that FBZ can treat cancer by inhibiting the cancer cell’s glucose intake and acting as an interfering agent that blocks multiple cellular pathways in cancer cells.

The positive results of research about Fenbendazole as an anticancer agent mean the FDA could eventually approve the drug for treating human ailments, including cancer. This could save a considerable amount of time and money in developing new cancer-fighting drugs that are more affordable and accessible.